Tivic Health Systems, Inc. financial data

Symbol
TIVC on Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
Location
47685 Lakeview Blvd, Fremont, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 432 % +8.94%
Quick Ratio 85.4 % +28.8%
Debt-to-equity 30.3 % -21.2%
Return On Equity -201 % -8.28%
Return On Assets -155 % -15%
Operating Margin -665 % +1.28%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.27M shares +464%
Common Stock, Shares, Outstanding 6.24M shares +326%
Entity Public Float 3M USD -76.9%
Common Stock, Value, Issued 1K USD
Weighted Average Number of Shares Outstanding, Basic 6.19M shares +420%
Weighted Average Number of Shares Outstanding, Diluted 6.19M shares +420%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 957K USD -21.9%
Cost of Revenue 711K USD -21.3%
Research and Development Expense 1.34M USD -22.5%
Selling and Marketing Expense 1.68M USD -10.9%
General and Administrative Expense 3.59M USD -27.8%
Operating Income (Loss) -6.36M USD +22.9%
Nonoperating Income (Expense) 0 USD
Net Income (Loss) Attributable to Parent -6.42M USD +22.2%
Earnings Per Share, Basic 7.2 USD/shares +84.5%
Earnings Per Share, Diluted 7.2 USD/shares +84.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 2.19M USD -57.7%
Accounts Receivable, after Allowance for Credit Loss, Current 9K USD -93.1%
Inventory, Net 731K USD -21.2%
Assets, Current 3.16M USD -51%
Property, Plant and Equipment, Net 119K USD -4.03%
Operating Lease, Right-of-Use Asset 304K USD -36.8%
Other Assets, Noncurrent 34K USD 0%
Assets 3.39M USD -51.6%
Accounts Payable, Current 333K USD -47.8%
Employee-related Liabilities, Current 40K USD
Liabilities, Current 560K USD -44%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 560K USD -54.9%
Retained Earnings (Accumulated Deficit) -42.1M USD -18%
Stockholders' Equity Attributable to Parent 2.83M USD -50.8%
Liabilities and Equity 3.39M USD -51.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.67M USD +31.3%
Net Cash Provided by (Used in) Financing Activities -61K USD -101%
Net Cash Provided by (Used in) Investing Activities -94K USD -1467%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 6.24M shares +326%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.73M USD -205%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.19M USD -57.7%
Deferred Tax Assets, Valuation Allowance 7.57M USD +4.9%
Deferred Tax Assets, Gross 7.67M USD +4.18%
Operating Lease, Liability 321K USD -36.4%
Depreciation 1K USD -50%
Payments to Acquire Property, Plant, and Equipment 94K USD +1467%
Lessee, Operating Lease, Liability, to be Paid 335K USD -38.3%
Property, Plant and Equipment, Gross 159K USD
Operating Lease, Liability, Current 180K USD -1.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 210K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 178K USD -15.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 14K USD -63.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 178K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 6.76M USD +3.41%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 98K USD -14.8%
Operating Lease, Payments 138K USD -29.6%
Additional Paid in Capital 44.9M USD +8.43%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 5K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 97K USD -32.2%
Share-based Payment Arrangement, Expense 224K USD -31.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%